MS Hospital in Ry
Ry, Jylland, 8680, Denmark
NCT Number: NCT01752660
In the last decade physical exercise has become an accepted and integrated part of rehabilitation in patients with multiple sclerosis (MS). However, no studies have evaluated whether the most severely disabled patients can tolerate and benefit from exercise therapy. The purpose of this study is therefore to evaluate the feasibility of endurance training in severely disabled patients with MS.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
Ry, Jylland, 8680, Denmark
For many years, patients with multiple sclerosis (MS) have been advised not to participate in physical exercise. This advice was given in part because some patients were reported to experience symptom instability during exercise as a consequence of increased body temperature. A further argument was that avoiding exercise would preserve energy and thereby result in less fatigue, leaving more energy for activities of daily living. During the last decade, it has been more common to recommend exercise for MS patients, because of its recently proven beneficial effects in these patients.
Resistance- and endurance training constitutes the two extremes of basic physical exercise. To gain insight into the effects of exercise it therefore makes sense to understand the extremes. In mild to moderately impaired MS patients endurance training is well tolerated and providing beneficial effects. However, this exercise modality has not yet been tested in severely disabled patients, and it is therefore unclear if endurance training is feasible and beneficial in these patients. The investigators have, therefore, designed a feasibility study evaluating the effects of 4 weeks of endurance training in severely disabled MS patients (Expanded Disability Status Scale score > 6).
Patients are inpatients at one of the national MS hospitals and endurance training is added to the usual care, and compared to usual care only (control group). Exercise frequency is 3 times per week, and intensity is controlled by HR measurements during exercise.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
->18 years
Exclusion criteria
Standard care during a 4 week inpatient stay at a Danish multiple sclerosis rehabilitation center added 3 weekly sessions of endurance training for the upper extremity.
Standard care during a 4 week inpatient stay at a Danish multiple sclerosis rehabilitation center.
Time frame: Exercise compliance is registered immediatly after all planned exercise sessions during the 4 week intervention
Compliance to exercise is registered and serve as the primary outcome.
Time frame: Number of participants who drop out is registered at the post measurement just after the intervention.
Time frame: 1-2 day before the intervention and 1-2days after the 4 week intervention peak oxygen is measured
Measurement of peak oxygen consumption during a ramp protocol on armergometer.
Time frame: 1-2 day before the intervention and 1-2days after the 4 week intervention the box and block test is performed
Time frame: 1-2 day before the intervention and 1-2days after the 4 week intervention the sit to stand test is performed
Time frame: 1-2 day before the intervention and 1-2days after the 4 week intervention the handgrip test is performed
Time frame: 1-2 day before the intervention and 1-2days after the 4 week intervention the wheel-chair test is performed
University of Aarhus
Other
Endurance Training in Severely Disabled Patients With MS - a Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03963375
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
St Louis, Missouri, United States
View Trial DetailsNCT02511028
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Bethesda, Maryland, United States
View Trial DetailsNCT07175792
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Diepenbeek, Belgium
View Trial DetailsNCT07726667
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Gaziantep, Gaz, Turkey (Türkiye)
View Trial Details